General Information of Drug (ID: DMICKCQ)

Drug Name
Adagloxad simolenin
Indication
Disease Entry ICD 11 Status REF
Triple negative breast cancer 2C60-2C65 Phase 3 [1]
Breast cancer 2C60-2C65 Phase 2/3 [2]
Drug Type
Vaccine
Cross-matching ID
TTD ID
DMS5N4

References

1 ClinicalTrials.gov (NCT03562637) Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)